The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...